查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1285861

骨科市場 - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 237 Pages | 商品交期: 2-10個工作天內

價格

骨科市場- 報告範圍

TMR關於全球骨科市場的報告研究了過去以及當前的成長趨勢和機會，以獲得對2023年至2031年預測期間市場指標的寶貴見解。報告提供了2017-2031年全球骨科市場的收入，考慮到2023年為基準年，2031年為預測年。報告還提供了2023年至2031年全球骨科市場的複合年成長率（CAGR %）。

該報告是在廣泛研究後編寫的。一級研究涉及大部分的研究工作，其中分析師與關鍵的意見領袖、行業領袖和意見製造者進行了訪談。二級研究包括參考主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解等離子體材料市場。

該報告深入研究了全球等離子體材料市場的競爭格局。在全球矯形外科市場運作的主要參與者已被確定，其中每一個都在各種屬性方面進行了分析。公司概況、財務狀況、最近的發展和SWOT是本報告中對全球矯形外科市場參與者的屬性描述。

目錄

第一章：前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 研究重點

第二章：假設和研究方法

第三章：執行摘要：全球市場

第四章：市場概述

  • 簡介
    • 細分市場的定義
  • 概述
  • 市場動態
    • 驅動力
    • 限制因素
    • 機會
  • 2017-2031年全球市場分析和預測
    • 市場收入預測

第五章：關鍵洞察力

  • 主要市場趨勢
  • 合併與收購
  • 在市場上營運的前五名玩家的策略
  • 骨科疾病的發生率：按主要國家分類
  • 外科手術的數量
  • 主要國家的監管和報銷情況
  • Covid-19大流行病對行業的影響

第六章：全球市場分析與預測：按產品分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按產品分類，2017-2031年
    • 異體移植
    • 異種移植
    • 合成骨移植
      • 羥基磷灰石
      • B-磷酸三鈣(B-TCP)
      • 生物氣
      • 生物活性玻璃
      • 其他
    • 去礦化骨基質(DBM)
    • 視覺補充劑
    • 富含血小板的血漿(PRP)
    • 骨髓濃縮液(BMAC)
    • 其他產品
  • 市場吸引力分析：按產品分類

第七章：全球市場分析和預測：按應用分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按應用分類，2017-2031年
    • 脊柱融合
    • 創傷修復
    • 重建手術
    • 骨折
    • 骨關節炎
    • 頜面和牙科應用
    • 其他應用
  • 市場吸引力分析：按應用分類

第八章：全球市場分析與預測：按終端用戶分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院
    • 骨科診所
    • 其他
  • 市場吸引力分析：按終端用戶分類

第九章：全球市場分析和預測：按地區分類

  • 主要研究結果
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第十章：北美市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品分類，2017-2031年
    • 異體移植
    • 異種移植
    • 合成骨移植
      • 羥基磷灰石
      • B-磷酸三鈣(B-TCP)
      • 生物氣
      • 生物活性玻璃
      • 其他
    • 去礦化骨基質(DBM)
    • 視覺補充劑
    • 富含血小板的血漿(PRP)
    • 骨髓濃縮液(BMAC)
    • 其他
  • 市場價值預測：按應用，2017-2031年
    • 脊柱融合
    • 創傷修復
    • 重建手術
    • 骨折
    • 骨關節炎
    • 頜面和牙科應用
    • 其他應用
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院
    • 骨科診所
    • 其他
  • 市場價值預測：按國家分類，2017-2031年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按產品分類
    • 按應用分類
    • 按終端用戶
    • 按國家分類

第11章：歐洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 異體移植
    • 異種移植
    • 合成骨移植
      • 羥基磷灰石
      • B-磷酸三鈣(B-TCP)
      • 生物氣
      • 生物活性玻璃
      • 其他
    • 去礦化骨基質(DBM)
    • 視覺補充劑
    • 富含血小板的血漿(PRP)
    • 骨髓濃縮液(BMAC)
    • 其他
  • 市場價值預測：按應用，2017-2031年
    • 脊柱融合
    • 創傷修復
    • 重建手術
    • 骨折
    • 骨關節炎
    • 頜面和牙科應用
    • 其他應用
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院
    • 骨科診所
    • 其他
  • 市場價值預測：按國家/次區域，2017-2031年
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按應用分類
    • 按終端用戶
    • 按國家/次區域分類

第十二章：亞太地區市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 異體移植
    • 異種移植
    • 合成骨移植
      • 羥基磷灰石
      • B-磷酸三鈣(B-TCP)
      • 生物氣
      • 生物活性玻璃
      • 其他
    • 去礦化骨基質(DBM)
    • 視覺補充劑
    • 富含血小板的血漿(PRP)
    • 骨髓濃縮液(BMAC)
    • 其他
  • 市場價值預測：按應用，2017-2031年
    • 脊柱融合
    • 創傷修復
    • 重建手術
    • 骨折
    • 骨關節炎
    • 頜面和牙科應用
    • 其他應用
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院
    • 骨科診所
    • 其他
  • 市場價值預測：按國家/次區域，2017-2031年
    • 中國
    • 日本
    • 印度
    • 澳大利亞和新西蘭
    • 亞太其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按應用分類
    • 按終端用戶
    • 按國家/次區域分類

第13章：拉美市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 異體移植
    • 異種移植
    • 合成骨移植
      • 羥基磷灰石
      • B-磷酸三鈣(B-TCP)
      • 生物氣
      • 生物活性玻璃
      • 其他
    • 去礦化骨基質(DBM)
    • 視覺補充劑
    • 富含血小板的血漿(PRP)
    • 骨髓濃縮液(BMAC)
    • 其他
  • 市場價值預測：按應用，2017-2031年
    • 脊柱融合
    • 創傷修復
    • 重建手術
    • 骨折
    • 骨關節炎
    • 頜面和牙科應用
    • 其他應用
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院
    • 骨科診所
    • 其他
  • 市場價值預測：按國家分類，2017-2031年
    • 巴西
    • 墨西哥
    • 拉美其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按應用分類
    • 按終端用戶
    • 按國家/次區域分類

第十四章：中東和非洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 異體移植
    • 異種移植
    • 合成骨移植
      • 羥基磷灰石
      • B-磷酸三鈣(B-TCP)
      • 生物氣
      • 生物活性玻璃
      • 其他
    • 去礦化骨基質(DBM)
    • 視覺補充劑
    • 富含血小板的血漿(PRP)
    • 骨髓濃縮液(BMAC)
    • 其他
  • 市場價值預測：按應用，2017-2031年
    • 脊柱融合
    • 創傷修復
    • 重建手術
    • 骨折
    • 骨關節炎
    • 頜面和牙科應用
    • 其他應用
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院
    • 骨科診所
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 海灣合作委員會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按應用分類
    • 按終端用戶
    • 按國家/次區域分類

第十五章：競爭格局

  • 市場參與者- 競爭矩陣（按公司層級和規模）。
  • 市場佔有率/排名分析：按公司，2022年
  • 公司簡介
    • Alphatec Spine, Inc.
    • Arthrex
    • Bioventus LLC
    • Exactech, Inc.
    • Global Medical, Inc.
    • Integra Lifesciences
    • Medtronic
    • MTF Biologics
    • RTI Surgical
    • Sano Orthopedics
    • Sanofi
    • Seikagaku Corporation
    • Stryker
    • Zimmer Biomet
Product Code: TMRGL1747

Orthobiologics Market - Scope of Report

TMR's report on the global Orthobiologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Orthobiologics Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Orthobiologics Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Orthobiologics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Orthobiologics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Orthobiologics market.

The report delves into the competitive landscape of the global Orthobiologics market. Key players operating in the global Orthobiologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Orthobiologics Market profiled in this report.

Key Questions Answered in Global Orthobiologics Market Report:

  • What is the sales/revenue generated by Orthobiologics across all regions during the forecast period?
  • What are the opportunities in the global Orthobiologics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Orthobiologics Market - Research Objectives and Research Approach

The comprehensive report on the global Orthobiologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Orthobiologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Orthobiologics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Market Trends
  • 5.2. Merger & Acquisition
  • 5.3. Strategies of Top Five Players Operating in the Market
  • 5.4. Incidence of Orthopedic Disorder, by Key Countries
  • 5.5. Number of Surgical Procedures
  • 5.6. Regulatory and Reimbursement Scenario by Key Countries
  • 5.7. Covid-19 Pandemic Impact on the Industry

6. Global Orthobiologics Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Allografts
    • 6.3.2. Xenografts
    • 6.3.3. Synthetic Bone Grafts
      • 6.3.3.1. Hydroxyapatite
      • 6.3.3.2. B-tricalcium Phosphate (B-TCP)
      • 6.3.3.3. BiPhasic
      • 6.3.3.4. Bioactive Glass
      • 6.3.3.5. Others
    • 6.3.4. Demineralized Bone Matrix (DBM)
    • 6.3.5. Viscosupplementation
    • 6.3.6. Platelet-rich Plasma (PRP)
    • 6.3.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 6.3.8. Others
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Orthobiologics Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Spinal Fusion
    • 7.3.2. Trauma Repair
    • 7.3.3. Reconstructive Surgeries
    • 7.3.4. Fractures
    • 7.3.5. Osteoarthritis
    • 7.3.6. Maxillofacial & Dental Applications
    • 7.3.7. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Orthobiologics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Orthopedic Clinics
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Orthobiologics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Orthobiologics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Allografts
    • 10.2.2. Xenografts
    • 10.2.3. Synthetic Bone Grafts
      • 10.2.3.1. Hydroxyapatite
      • 10.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 10.2.3.3. BiPhasic
      • 10.2.3.4. Bioactive Glass
      • 10.2.3.5. Others
    • 10.2.4. Demineralized Bone Matrix (DBM)
    • 10.2.5. Viscosupplementation
    • 10.2.6. Platelet-rich Plasma (PRP)
    • 10.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 10.2.8. Others
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Spinal Fusion
    • 10.3.2. Trauma Repair
    • 10.3.3. Reconstructive Surgeries
    • 10.3.4. Fractures
    • 10.3.5. Osteoarthritis
    • 10.3.6. Maxillofacial & Dental Applications
    • 10.3.7. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Orthopedic Clinics
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Orthobiologics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Allografts
    • 11.2.2. Xenografts
    • 11.2.3. Synthetic Bone Grafts
      • 11.2.3.1. Hydroxyapatite
      • 11.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 11.2.3.3. BiPhasic
      • 11.2.3.4. Bioactive Glass
      • 11.2.3.5. Others
    • 11.2.4. Demineralized Bone Matrix (DBM)
    • 11.2.5. Viscosupplementation
    • 11.2.6. Platelet-rich Plasma (PRP)
    • 11.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 11.2.8. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Spinal Fusion
    • 11.3.2. Trauma Repair
    • 11.3.3. Reconstructive Surgeries
    • 11.3.4. Fractures
    • 11.3.5. Osteoarthritis
    • 11.3.6. Maxillofacial & Dental Applications
    • 11.3.7. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Orthopedic Clinics
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Orthobiologics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Allografts
    • 12.2.2. Xenografts
    • 12.2.3. Synthetic Bone Grafts
      • 12.2.3.1. Hydroxyapatite
      • 12.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 12.2.3.3. BiPhasic
      • 12.2.3.4. Bioactive Glass
      • 12.2.3.5. Others
    • 12.2.4. Demineralized Bone Matrix (DBM)
    • 12.2.5. Viscosupplementation
    • 12.2.6. Platelet-rich Plasma (PRP)
    • 12.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 12.2.8. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Spinal Fusion
    • 12.3.2. Trauma Repair
    • 12.3.3. Reconstructive Surgeries
    • 12.3.4. Fractures
    • 12.3.5. Osteoarthritis
    • 12.3.6. Maxillofacial & Dental Applications
    • 12.3.7. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Orthopedic Clinics
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Orthobiologics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Allografts
    • 13.2.2. Xenografts
    • 13.2.3. Synthetic Bone Grafts
      • 13.2.3.1. Hydroxyapatite
      • 13.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 13.2.3.3. BiPhasic
      • 13.2.3.4. Bioactive Glass
      • 13.2.3.5. Others
    • 13.2.4. Demineralized Bone Matrix (DBM)
    • 13.2.5. Viscosupplementation
    • 13.2.6. Platelet-rich Plasma (PRP)
    • 13.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 13.2.8. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Spinal Fusion
    • 13.3.2. Trauma Repair
    • 13.3.3. Reconstructive Surgeries
    • 13.3.4. Fractures
    • 13.3.5. Osteoarthritis
    • 13.3.6. Maxillofacial & Dental Applications
    • 13.3.7. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Orthopedic Clinics
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Orthobiologics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Allografts
    • 14.2.2. Xenografts
    • 14.2.3. Synthetic Bone Grafts
      • 14.2.3.1. Hydroxyapatite
      • 14.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 14.2.3.3. BiPhasic
      • 14.2.3.4. Bioactive Glass
      • 14.2.3.5. Others
    • 14.2.4. Demineralized Bone Matrix (DBM)
    • 14.2.5. Viscosupplementation
    • 14.2.6. Platelet-rich Plasma (PRP)
    • 14.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 14.2.8. Others
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Spinal Fusion
    • 14.3.2. Trauma Repair
    • 14.3.3. Reconstructive Surgeries
    • 14.3.4. Fractures
    • 14.3.5. Osteoarthritis
    • 14.3.6. Maxillofacial & Dental Applications
    • 14.3.7. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Orthopedic Clinics
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share/Ranking Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Alphatec Spine, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Strategic Overview
    • 15.3.2. Arthrex
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
    • 15.3.3. Bioventus LLC
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Strategic Overview
    • 15.3.4. Exactech, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Strategic Overview
    • 15.3.5. Global Medical, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Strategic Overview
    • 15.3.6. Integra Lifesciences
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Strategic Overview
    • 15.3.7. Medtronic
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
    • 15.3.8. MTF Biologics
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. RTI Surgical
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Strategic Overview
    • 15.3.10. Sano Orthopedics
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Strategic Overview
    • 15.3.11. Sanofi
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Strategic Overview
    • 15.3.12. Seikagaku Corporation
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Strategic Overview
    • 15.3.13. Stryker
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Strategic Overview
    • 15.3.14. Zimmer Biomet
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Product Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Strategic Overview

List of Tables

  • Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017-2031, by Application
  • Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Orthobiologics Market Value Share, by Product, 2021
  • Figure 03: Global Orthobiologics Market Value Share, by Application, 2021
  • Figure 04: Global Orthobiologics Market Value Share, by End-user, 2021
  • Figure 05: Global Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 06: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 07: Global Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 08: Global Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 09: Global Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 10: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 11: Global Orthobiologics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 12: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 13: North America Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: North America Orthobiologics Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 15: North America Orthobiologics Market Attractiveness Analysis, by Country, 2023-2031 
  • Figure 16: North America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 17: North America Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 18: North America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 19: North America Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 20: North America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 21: North America Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 22: Europe Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 24: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Europe Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 26: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 27: Europe Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 28: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 29: Europe Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 30: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 31: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 33: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 35: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 36: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 37: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 38: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 39: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 40: Latin America Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 41: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 42: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 43: Latin America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 44: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 45: Latin America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 46: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 47: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 48: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 50: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 51: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 52: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 53: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 54: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 55: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 56: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 57: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Company Share Analysis, 2021